Aspirin May Lower Risk of Lethal Prostate Cancer But confirmation needed before a firm recommendation can be made

Men with prostate cancer had almost a 40% lower risk of dying of the disease if they were taking aspirin for cardiovascular protection, a large cohort study showed. The hazard ratio for prostate cancer death was 0.61 (95% CI 0.47-0.78) for men who reported taking aspirin more than three times a week versus those who reported less frequent or no aspirin use. Aspirin prophylaxis also was associated with a 24% reduction in the hazard for lethal prostate cancer, defined as metastatic disease or death. Total prostate cancer and the risk of high-grade or locally advanced disease did not decrease with aspirin use. http://www.medpagetoday.com/MeetingCoverage/ASCOGU/55525?xid=nl_mpt_DHE_2016-01-06&eun=g721819d0r